TI
VRTX icon

Tidal Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Tidal Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.5M Buy
95,685
+3,604
+4% +$1.6M 0.08% 240
2026
Q1 		$41M Buy
92,081
+75,243
+447% +$35.1M 0.09% 216
2025
Q4 		$7.63M Buy
16,838
+2,206
+15% +$951K 0.02% 531
2025
Q3 		$5.73M Buy
14,632
+367
+3% +$153K 0.01% 564
2025
Q2 		$6.35M Sell
14,265
-126
-0.9% -$58.1K 0.04% 414
2025
Q1 		$6.98M Sell
14,391
-3,962
-22% -$1.85M 0.06% 335
2024
Q4 		$7.39M Buy
18,353
+6,672
+57% +$3.09M 0.06% 330
2024
Q3 		$5.43M Sell
11,681
-303
-3% -$146K 0.06% 313
2024
Q2 		$5.62M Sell
11,984
-3,098
-21% -$1.34M 0.08% 239
2024
Q1 		$6.3M Buy
15,082
+4,036
+37% +$1.71M 0.1% 186
2023
Q4 		$4.49M Sell
11,046
-623
-5% -$230K 0.1% 166
2023
Q3 		$4.06M Sell
11,669
-3,260
-22% -$1.14M 0.12% 158
2023
Q2 		$5.25M Sell
14,929
-2,335
-14% -$787K 0.15% 115
2023
Q1 		$5.44M Sell
17,264
-6,867
-28% -$2.06M 0.18% 109
2022
Q4 		$6.97M Sell
24,131
-898
-4% -$274K 0.27% 69
2022
Q3 		$7.25M Buy
25,029
+8,281
+49% +$2.38M 0.3% 54
2022
Q2 		$4.72M Sell
16,748
-1,762
-10% -$472K 0.17% 103
2022
Q1 		$4.83M Buy
+18,510
New +$4.39M 0.14% 117
2021
Q4 		– Sell
-8,410
Closed -$1.53M – 1062
2021
Q3 		$1.53M Buy
8,410
+2,248
+36% +$439K 0.06% 219
2021
Q2 		$1.24M Buy
6,162
+3,337
+118% +$698K 0.05% 240
2021
Q1 		$607K Buy
2,825
+770
+37% +$169K 0.03% 262
2020
Q4 		$486K Buy
2,055
+607
+42% +$139K 0.03% 236
2020
Q3 		$394K Buy
1,448
+160
+12% +$44.1K 0.05% 175
2020
Q2 		$374K Sell
1,288
-509
-28% -$138K 0.05% 187
2020
Q1 		$428K Buy
1,797
+492
+38% +$113K 0.13% 131
2019
Q4 		$286K Sell
1,305
-410
-24% -$83K 0.12% 149
2019
Q3 		$291K Buy
+1,715
New +$303K 0.13% 133

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Tidal Investments's VRTX Position: Q2 2026 in Review

Tidal Investments increased its Vertex Pharmaceuticals (VRTX) stake by 3.9% in Q2 2026, buying an estimated $1.6M and bringing the position to 95,685 shares worth $47.5M. The position accounts for 0.08% of the portfolio, ranked #240.

Tidal Investments first reported a position in VRTX in Q3 2019 and has held it in 27 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Tidal Investments held 95,685 shares of Vertex Pharmaceuticals worth $47.5M as of Q2 2026.
  • Tidal Investments bought 3,604 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.6M.
  • Vertex Pharmaceuticals made up 0.08% of Tidal Investments's portfolio in Q2 2026, its #240 holding.
  • Tidal Investments first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.